SOPHiA GENETICS™ is excited to be a part of the European Society of Human Genetics annual meeting,...
ESHG 2023
read more
Events
ASCO 2023
SOPHiA GENETICS™ is excited to be a part of the American Society for Clinical Oncology annual...
HIMSS 2023
SOPHiA GENETICS™ is excited to be a part of the Healthcare Information and Management Systems...
AACR 2023
SOPHiA GENETICS™ is excited to be a part of the American Association for Cancer Research annual...
ACMG 2023
SOPHiA GENETICS™ is excited to be a part of the American College of Medical Genetics annual...
Clinical validation of novel RNA fusion detection for NSCLC with SOPHiA DDM tm Dx RNAtarget Oncology
Clinical validation of novel RNA fusion detection for NSCLC&...
Evaluation of a low-pass whole genome sequencing-based solution for HRD detection supported by deep learning algorithms
What’s New? CE-IVD Oncology Applications by SOPHiA GENETICS™...
Somatic RNA variant calling in solid tumors
About Gene fusions are the latest type of biomarker to receive broad applicability in cancer...
European Congress of Pathology
SOPHiA GENETICS is excited to be part of the 34th European Congress of Pathology 2022 annual...
BioData World Congress
SOPHiA GENETICS is excited to be a part of the BioData World Congress 2022...
ASH 2022
SOPHiA GENETICS™ is excited to be a part of the American Society of...
Detecting HRD in ovarian cancers using a deep learning solution based on low pass whole-genome sequencing
About Deficiency in the homologous recombination repair system represent up to 50% of the ovarian,...